Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 30
Filtrer
1.
Front Oral Health ; 5: 1428008, 2024.
Article de Anglais | MEDLINE | ID: mdl-39021475

RÉSUMÉ

Oral lichen sclerosus (OLS) represents a diagnostic challenge even for expert dermatologists due to its rarity and subtle clinical manifestations. Only few cases have been reported in literature to date. OLS typically presents with whitish macules in the oral cavity. Histopathological examination remains crucial for definitive diagnosis, with characteristic features including epithelial atrophy, subepithelial hyalinization, loss of elastic fibers, and lymphocytic infiltration. Management strategies vary depending on lesion size and symptomatic presentation, with topical or intralesional corticosteroids being the most commonly used treatment modalities. Long-term monitoring is recommended due to the potential for malignant transformation, although no cases have been reported to date. Greater awareness and understanding of OLS are essential for accurate diagnosis and effective management. Based on these findings, we recommend performing an accurate evaluation of the oral mucosa, especially when dealing with patients affected by genital or extragenital lichen sclerosus (LS). Moreover, we emphasize the importance of multidisciplinary collaboration between dermatologists and other specialists of oral disorders, such as dentists. This short review briefly summarizes available data on OLS, highlighting its diverse clinical presentations and diagnostic challenges. Despite its infrequent occurrence, OLS should be considered in the differential diagnosis of white macules in the oral cavity.

2.
Mol Ther ; 32(2): 372-383, 2024 Feb 07.
Article de Anglais | MEDLINE | ID: mdl-38053334

RÉSUMÉ

Epidermolysis bullosa simplex (EBS) is a rare skin disease inherited mostly in an autosomal dominant manner. Patients display a skin fragility that leads to blisters and erosions caused by minor mechanical trauma. EBS phenotypic and genotypic variants are caused by genetic defects in intracellular proteins whose function is to provide the attachment of basal keratinocytes to the basement membrane zone and most EBS cases display mutations in keratin 5 (KRT5) and keratin 14 (KRT14) genes. Besides palliative treatments, there is still no long-lasting effective cure to correct the mutant gene and abolish the dominant negative effect of the pathogenic protein over its wild-type counterpart. Here, we propose a molecular strategy for EBS01 patient's keratinocytes carrying a monoallelic c.475/495del21 mutation in KRT14 exon 1. Through the CRISPR-Cas9 system, we perform a specific cleavage only on the mutant allele and restore a normal cellular phenotype and a correct intermediate filament network, without affecting the epidermal stem cell, referred to as holoclones, which play a crucial role in epidermal regeneration.


Sujet(s)
Épidermolyse bulleuse simple , Humains , Épidermolyse bulleuse simple/génétique , Épidermolyse bulleuse simple/thérapie , Épidermolyse bulleuse simple/métabolisme , Allèles , Systèmes CRISPR-Cas , Kératinocytes/métabolisme , Mutation , Cellules souches/métabolisme
4.
Clin Exp Dermatol ; 45(7): 824-830, 2020 Oct.
Article de Anglais | MEDLINE | ID: mdl-32386432

RÉSUMÉ

Mesenchymal stem cells (MSCs) have recently been shown to have not only regenerative capabilities but also immunomodulating properties. For this reason, they are currently under investigation in clinical trials for the treatment of several autoimmune systemic disorders. Psoriasis is a systemic immune-mediated disease for which MSCs could have therapeutic potential. We analysed the existing literature with regard to MSC-based strategies for the treatment of psoriasis, using the MEDLINE, Embase, Scopus and Cochrane Library electronic databases from inception to the date of study. A number of studies confirm the involvement of MSCs in psoriasis pathogenesis and therefore designate MSCs as an important potential therapeutic tool in this setting. Preclinical data are mostly based on imiquimod-induced murine models of psoriasis, and confirm the anti-inflammatory and immunomodulatory action of MSCs in the setting of psoriasis. Six patients affected by psoriasis were described in four clinical studies. Despite significant differences in terms of therapeutic protocols and clinical outcomes, the MSC-based regimens were efficacious in 100% of the cases. Despite more data still being needed, MSCs could be a promising therapy for psoriasis.


Sujet(s)
Sang foetal/transplantation , Imiquimod/effets indésirables , Transplantation de cellules souches mésenchymateuses/effets indésirables , Cellules souches mésenchymateuses/immunologie , Psoriasis/thérapie , Adjuvants immunologiques/administration et posologie , Adjuvants immunologiques/effets indésirables , Adulte , Animaux , Prolifération cellulaire/effets des médicaments et des substances chimiques , Essais cliniques comme sujet , Cytokines/immunologie , Cytokines/métabolisme , Femelle , Sang foetal/cytologie , Humains , Imiquimod/administration et posologie , Immunomodulation/immunologie , Perfusions veineuses , Kératinocytes/anatomopathologie , Mâle , Transplantation de cellules souches mésenchymateuses/méthodes , Cellules souches mésenchymateuses/anatomopathologie , Souris , Adulte d'âge moyen , Modèles animaux , Psoriasis/immunologie , Psoriasis/anatomopathologie , Lymphocytes T/effets des médicaments et des substances chimiques , Lymphocytes T/immunologie , Lymphocytes T/anatomopathologie , Résultat thérapeutique
6.
J Eur Acad Dermatol Venereol ; 33(1): 32-41, 2019 Jan.
Article de Anglais | MEDLINE | ID: mdl-30022555

RÉSUMÉ

Favre-Racouchot disease (FRD) is a relatively common dermatosis induced by chronic sun exposure. FRD is clinically and histologically characterized by the presence of both comedones and cysts in the context of an elastotic degeneration of the dermis. Those lesions are mainly located in the face, especially in the malar and periorbital areas. Smoking and radiotherapy seem to play a role in the pathogenesis together with UV exposure. The disease affects predominantly the aged population and seems to be a problem of mainly aesthetic concern. No official guidelines are available for the treatment of FRD; most common therapeutic strategies are represented by topical retinoids and laser treatments. The goal of our review was to identify the principal clinical and epidemiological characteristics of FRD and to analyse all the therapeutic strategies available. We also focused our attention on the follow-up of this particular dermatosis. Our aim was therefore to suggest alternative possible strategies for both the treatment and the follow-up of these patients. Our data support the efficacy of carbon dioxide laser and topical retinoids in the setting of FRD, but we also suggest considering alternative treatments, such as plasma exeresis. We also recommend planning both a short-term and a long-term follow-up visit, as the majority of relapses is observed after 10-12 months.


Sujet(s)
Dermatoses faciales/thérapie , Rétinoïdes/usage thérapeutique , Administration par voie cutanée , Kystes/diagnostic , Kystes/épidémiologie , Kystes/thérapie , Dermatoses faciales/diagnostic , Dermatoses faciales/épidémiologie , Humains , Lasers à gaz/usage thérapeutique , Rétinoïdes/administration et posologie
10.
Clin Otolaryngol ; 42(4): 831-836, 2017 Aug.
Article de Anglais | MEDLINE | ID: mdl-28004496

RÉSUMÉ

OBJECTIVES: The goal of this study was to compare maxillary sinus (MS) volume in patients with, or without, maxillary fungal ball. DESIGN: Monocentric retrospective study performed on 115 patient CT scans. SETTINGS: We defined two groups of patients according to the absence (control group) or the presence (fungal ball group) of unilateral fungal ball in the MS. Sinus 3D reconstruction was created from CT scan. PARTICIPANTS: Control group: 71 patients (36 women - 50.7%); mean age was 51 years. Fungal ball group: 44 patients (29 women - 65.9%); mean age was 54.5 years. MAIN OUTCOME MEASURE: The univariate association between MS volume and sinus covariates was tested by anova. Multivariate analysis was made including all variables statistically significant in univariate analysis. RESULTS: In the control group, mean MS volume was 14 766 mm3 . The volumes of the two MSs were not statistically different in the control group (P = 0.145). In the fungal ball group, mean MS volume was 15 982 mm3 . Fungal ball was found in the smallest MS in 41 of 44 cases. Univariate analysis showed a statistical difference between the pathological and the non-pathological MS volumes (P < 10-4 ). Multivariate analysis confirmed the correlation between MS volume and the presence of a fungal ball (P < 10-4 ). CONCLUSIONS: This study suggests that maxillary fungal ball is associated with a smaller size of the affected MS.


Sujet(s)
Sinus maxillaire/microbiologie , Sinus maxillaire/anatomopathologie , Mycoses/microbiologie , Mycoses/anatomopathologie , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Femelle , Humains , Mâle , Adulte d'âge moyen , Analyse multifactorielle , Taille d'organe , Études rétrospectives
11.
Eur J Obstet Gynecol Reprod Biol ; 206: 6-11, 2016 Nov.
Article de Anglais | MEDLINE | ID: mdl-27612213

RÉSUMÉ

OBJECTIVE: To explore maternal cardiac deceleration capacity (DC), a marker of autonomic function derived from electrocardiographic (ECG) signals, in pregnancies complicated by intrauterine growth restriction (IUGR) and hypertensive disorders of pregnancy (HDP) associated to IUGR (HDP-IUGR) or to appropriate for gestational age fetal growth (HDP-AGAf). METHODS: Prospective single center case-control study conducted at Buzzi Children's Hospital, Milan. Maternal ECGs were analyzed by Phase Rectified Signal Averaging (PRSA) method to obtain cardiac DC in women with: HDP-IUGR, HDP-AGAf, severe-IUGR, mild-IUGR and uncomplicated pregnancies. IUGR was defined as abdominal circumference <5th centile; severe-IUGR was associated with umbilical artery Doppler pulsatility index >2 standard deviations. Non-parametric tests were adopted. RESULTS: 269 women were recruited. Women with HDP-IUGR (n=35) showed significantly higher cardiac DC compared both to controls (n=141) (p=0.003) and women with HDP-AGAf (n=18) (p=0.01). Women with severe-IUGR (n=14) showed significantly higher DC than controls (p=0.01). Women with mild-IUGR (n=61) as well as women with HDP-AGAf showed no differences in DC compared to controls (both p=0.3). CONCLUSIONS: Women with pregnancy complicated by severe placental failure, such as HDP-IUGR and severe IUGR, show significant autonomic alterations, as indicated by elevated cardiac DC. On the contrary, pregnancy complications such as HDP-AGAf and mild IUGR show no impact on maternal autonomic balance. We present a new approach to explore maternal autonomic cardiovascular regulation that might reflect the severity of placental vascular insufficiency.


Sujet(s)
Système nerveux autonome/physiopathologie , Retard de croissance intra-utérin/physiopathologie , Rythme cardiaque/physiologie , Coeur/physiopathologie , Hypertension artérielle gravidique/physiopathologie , Adulte , Système nerveux autonome/imagerie diagnostique , Études cas-témoins , Décélération , Électrocardiographie , Femelle , Retard de croissance intra-utérin/imagerie diagnostique , Humains , Hypertension artérielle gravidique/imagerie diagnostique , Placenta/imagerie diagnostique , Placenta/physiopathologie , Insuffisance placentaire/imagerie diagnostique , Insuffisance placentaire/physiopathologie , Grossesse , Études prospectives , Échographie prénatale , Artères ombilicales/imagerie diagnostique , Artères ombilicales/physiopathologie
12.
Case Rep Obstet Gynecol ; 2014: 801616, 2014.
Article de Anglais | MEDLINE | ID: mdl-25544919

RÉSUMÉ

Torsion of a gravid uterus is a rare obstetric emergency potentially lethal for the fetus and the mother. Some of the cases described in literature are associated with preexisting gynecologic conditions related to pelvic and uterine anatomy, even if most of cases remain unexplained. We report a case of acute 180-degree torsion of uterus at 33 weeks of gestation associated with abruptio placentae in a young Asian woman without apparent risk factors.

13.
J Neonatal Perinatal Med ; 7(3): 237-9, 2014 Jan 01.
Article de Anglais | MEDLINE | ID: mdl-25318627

RÉSUMÉ

In this case, we describe a newborn with prenatal diagnosis of congenital high airway obstruction syndrome (CHAOS), successfully managed with a cesarean section with delayed cord clamping 180 seconds. In case of prenatal diagnosis of CHAOS, prompt airway intervention at delivery allows survival of this otherwise fatal condition. Ex utero intrapartum treatment (EXIT) is considered the elective procedure to secure the fetal airway before the baby is completely separated from the maternal circulation. In cases where the EXIT procedure is not possible for maternal reasons (Ballantyne's syndrome), delayed cord clamping may serve as an alternative method to manage CHAOS.


Sujet(s)
Obstruction des voies aériennes/thérapie , Césarienne , Maladies du prématuré/thérapie , Soins périnatals/méthodes , Adulte , Obstruction des voies aériennes/congénital , Obstruction des voies aériennes/diagnostic , Femelle , Humains , Nouveau-né , Prématuré , Maladies du prématuré/diagnostic , Grossesse , Diagnostic prénatal , Réanimation/méthodes , Syndrome , Cordon ombilical
14.
Eur Ann Otorhinolaryngol Head Neck Dis ; 131(4): 233-8, 2014 Sep.
Article de Anglais | MEDLINE | ID: mdl-25106698

RÉSUMÉ

The authors present the guidelines of the French Oto-rhino-laryngology--Head and Neck Surgery Society (SFORL) regarding pain management in children and adults following tonsillectomy. A multidisciplinary work group was entrusted with a literature review. Guidelines were drawn up based on the articles retrieved and the group members' experience. They were read over by an editorial group independent of the work group. A coordination meeting drew up the final version. Guidelines were graded A, B or C or as professional agreement in decreasing order of level of evidence. At home, non-steroid anti-inflammatory drugs (NSAIDs) are recommended in association with paracetamol in elevated respiratory risk and especially obstructive sleep apnea syndrome; in elevated hemorrhagic risk (hemostasis disorder, surgical problems, etc.), tramadol is recommended. Two other treatment schedules (modified NSAIDs and corticosteroids) have not undergone dedicated study and should be assessed. Management of post-tonsillectomy pain in children is founded on individual risk/benefit analysis.


Sujet(s)
Analgésiques/usage thérapeutique , Codéine/usage thérapeutique , Gestion de la douleur/normes , Douleur postopératoire/traitement médicamenteux , Amygdalectomie/effets indésirables , Enfant , Enfant d'âge préscolaire , Humains , Nourrisson , Appréciation des risques
15.
Eur Ann Otorhinolaryngol Head Neck Dis ; 131(4): 227-32, 2014 Sep.
Article de Anglais | MEDLINE | ID: mdl-25106699

RÉSUMÉ

OBJECTIVES: The present clinical practice guidelines cover the entire field of management of post-tonsillectomy pain. Given the French and European regulatory restrictions on the use of codeine, an update appears necessary to clarify the management of post-tonsillectomy pain in adults. METHOD: A work group approached the issue of pain management, following the chronological pathway from initial consultation to postoperative period. As exhaustive a study of the literature as possible assessed the pain impact of the various surgical techniques and the efficacy of the various analgesia schedules. RESULTS: Guidelines on the management of post-tonsillectomy pain in adults were drawn up and graded, based on the levels of evidence of selected articles and on work group consensus. The guidelines stress the importance of patient information and seek to harmonize practice, reduce the risk of postoperative complications and above all improve control of post-tonsillectomy pain in adults.


Sujet(s)
Gestion de la douleur/normes , Douleur postopératoire/étiologie , Douleur postopératoire/thérapie , Amygdalectomie/effets indésirables , Adulte , Humains
16.
Minerva Pediatr ; 58(1): 77-89, 2006 Feb.
Article de Italien | MEDLINE | ID: mdl-16541011

RÉSUMÉ

The perinatal phase coincides, at its onset (22nd-23rd week of gestation, according to common acknowledgment), with the possible beginning of a extrauterine life susceptible of protraction. The 1st, for some the 4th, week of neonatal life marks the conclusion of the perinatal phase. There are several reasons to burden this period, to which a complex World Health Organization (WHO) document for Europe was dedicated in November 2000, with ethical issues. The profound immaturity that characterizes these extremely low weight newborns, of an approximate weight of 500 g, influences the poor survival prognosis (especially for those born within the 24th week), as well as the limitations concerning quality of life, often severe. Neonates born earlier than the 23rd week are at extreme risk, and rouse critical considerations regarding the choice of a health care program. A close monitoring of pregnancies at risk of premature termination, and a careful program of medical care for these extremely pre-terms, progressively implemented in the last 10-15 years, have given consistent results, reported in surveys of recent publication. From an ethical point of view, the problem of limitations within or beyond which to stretch intensive care interventions in Neonatal Intensive Care Unit (NICU) is still crucial, being the orientation between rational and emotional a difficult issue. Guidelines or behaviour proposals, variable with time and manifold in different countries, are reported. Naturally, the communication of a severe diagnosis to parents of a newborn even if not preterm-born falls also under the ethical issues of the perinatal period.


Sujet(s)
Périnatologie/éthique , Grossesse à haut risque , Éthique clinique , Europe , Femelle , Humains , Nouveau-né , Prématuré , Nourrisson très faible poids naissance , Unités de soins intensifs néonatals , Italie , Guides de bonnes pratiques cliniques comme sujet , Grossesse , Qualité de vie , Abstention thérapeutique/éthique
17.
Mech Dev ; 107(1-2): 119-31, 2001 Sep.
Article de Anglais | MEDLINE | ID: mdl-11520668

RÉSUMÉ

We analyzed the influence of presenilins on the genetic cascades that control neuronal differentiation in Xenopus embryos. Resembling sonic hedgehog (shh) overexpression, presenilin mRNA injection reduced the number of N-tubulin+ primary neurons and modulated Gli3 and Zic2 according to their roles in activating and repressing primary neurogenesis, respectively. Presenilin increased shh expression within its normal domain, mainly in the floor plate, whereas an antisense X-presenilin-alpha morpholino oligonucleotide reduced shh expression. Both shh and presenilin promoted cell proliferation and apoptosis, but the effects of shh were widely distributed, while those resulting from presenilin injection coincided with the range of shh signaling. We suggest that presenilin may modulate primary neurogenesis, proliferation, and apoptosis in the neural plate, through the enhancement of shh signaling.


Sujet(s)
Protéines membranaires/génétique , Protéines de tissu nerveux , Neurones/cytologie , Protéines de répression , Transactivateurs/génétique , Protéines de Xénope , Xenopus laevis/embryologie , Amyloid precursor protein secretases , Animaux , Apoptose , Aspartic acid endopeptidases , Différenciation cellulaire , Division cellulaire , Système nerveux central/embryologie , Protéines de liaison à l'ADN/génétique , Régulation négative , Embryon non mammalien/cytologie , Embryon non mammalien/métabolisme , Endopeptidases/métabolisme , Régulation de l'expression des gènes au cours du développement , Protéines Hedgehog , Hybridation in situ , Facteurs de transcription Krüppel-like , Protéines membranaires/physiologie , Mutagenèse dirigée , Oligonucléotides antisens , Préséniline-1 , ARN messager/génétique , ARN messager/métabolisme , RT-PCR , Transduction du signal , Transactivateurs/physiologie , Facteurs de transcription/génétique , Trétinoïne/pharmacologie , Tubuline/génétique , Tubuline/métabolisme , Xenopus laevis/génétique , Xenopus laevis/métabolisme , Protéine à doigts de zinc Gli3
18.
Development ; 126(19): 4257-65, 1999 Oct.
Article de Anglais | MEDLINE | ID: mdl-10477294

RÉSUMÉ

Previous work has shown that the posteriorising agent retinoic acid can accelerate anterior neuronal differentiation in Xenopus laevis embryos (Papalopulu, N. and Kintner, C. (1996) Development 122, 3409-3418). To elucidate the role of retinoic acid in the primary neurogenesis cascade, we investigated whether retinoic acid treatment of whole embryos could change the spatial expression of a set of genes known to be involved in neurogenesis. We show that retinoic acid expands the N-tubulin, X-ngnr-1, X-MyT1, X-&Dgr;-1 and Gli3 domains and inhibits the expression of Zic2 and sonic hedgehog in the neural ectoderm, whereas a retinoid antagonist produces opposite changes. In contrast, sonic and banded hedgehog overexpression reduced the N-tubulin stripes, enlarged the neural plate at the expense of the neural crest, downregulated Gli3 and upregulated Zic2. Thus, retinoic acid and hedgehog signaling have opposite effects on the prepattern genes Gli3 and Zic2 and on other genes acting downstream in the neurogenesis cascade. In addition, retinoic acid cannot rescue the inhibitory effect of Notch(ICD), Zic2 or sonic hedgehog on primary neurogenesis. Our results suggest that retinoic acid acts very early, upstream of sonic hedgehog, and we propose a model for regulation of differentiation and proliferation in the neural plate, showing that retinoic acid might be activating primary neurogenesis by repressing sonic hedgehog expression.


Sujet(s)
Protéines de Drosophila , Protéines d'insecte/métabolisme , Protéines de tissu nerveux , Protéines de répression , Transduction du signal , Transactivateurs , Trétinoïne/pharmacologie , Protéines de Xénope , Xenopus/embryologie , Xenopus/génétique , Animaux , Benzoates/pharmacologie , Division cellulaire , Chromanes/pharmacologie , Protéines de liaison à l'ADN/métabolisme , Régulation négative , Embryon non mammalien/métabolisme , Régulation de l'expression des gènes au cours du développement , Protéines Hedgehog , Facteurs de transcription Krüppel-like , Mésencéphale/embryologie , Modèles biologiques , Crête neurale/embryologie , Protéines/métabolisme , Rhombencéphale/embryologie , Facteurs de transcription/métabolisme , Tubuline/métabolisme , Protéine à doigts de zinc Gli3
19.
Minerva Ginecol ; 47(7-8): 315-8, 1995.
Article de Italien | MEDLINE | ID: mdl-8559442

RÉSUMÉ

Since the initial observation of an association between low maternal serum aFP and trisomies noninvasive for chromosomal abnormalities is an obvious goal of genetics and obstetricians. Here are reported the results of a biochemical screening for fetal trisomies study based on the dosages of maternal serum aFP, bHCG and uE3 at 16 week gestational age on 1166 pregnant women without risk factors for genetical abnormalities. Sensitivity, positive predictivity and negative predictivity of the screening were 50%, 42.86% and 99.74% respectively.


Sujet(s)
Syndrome de Down/sang , Maladies foetales/sang , Adulte , Marqueurs biologiques/sang , Gonadotrophine chorionique/sang , Syndrome de Down/imagerie diagnostique , Oestriol/sang , Femelle , Maladies foetales/imagerie diagnostique , Humains , Grossesse , Deuxième trimestre de grossesse , Études prospectives , Échographie prénatale , Alphafoetoprotéines/analyse
20.
Ultrasound Obstet Gynecol ; 4(4): 310-5, 1994 Jul 01.
Article de Anglais | MEDLINE | ID: mdl-12797166

RÉSUMÉ

As several studies have reported that 35% of patients with polycystic ovary syndrome are obese and that this syndrome seems to originate during the early phase of sexual maturation, we undertook a study of such subjects. We studied ultrasound and hormonal findings in 49 obese girls aged from 7.9 to 19.10 years, with a mean excess weight of 44%; 23 premenarcheal girls and 26 postmenarcheal girls with mean gynecological age of 2.5 years. As controls, we studied 18 girls in the pubertal phase and 17 healthy girls with regular menses, matched for age and gynecological age. Pelvic ultrasonography was carried out in all girls and estrone, estradiol, progesterone, prolactin, follicle stimulating hormone, luteinizing hormone, sex hormone binding globulin (SHBG), testosterone, free testosterone, dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEA-S), androstenedione and 17-hydroxyprogesterone (17-OHP) were measured by radioimmunoassay in 11 of the 18 postmenarcheal girls. Five girls (10.2%) with excess weight of > 40% presented with mild or severe hirsutism based on Ferriman and Gallway scores; six (12.2%) presented with acne and 14 (28.5%) presented with acanthosis nigricans.Hormonal evaluation showed elevated levels of estrone (p < 0.005) and testosterone (p < 0.01) but lower than normal levels of SHBG (p < 0.05) and estradiol (p <0.05). On the basis of our results, 23%) of the postmenarcheal obese subjects showed clinical, hormonal and ultrasonographic signs of polycystic ovaries, and 23% of postmenarcheal obese girls showed multifollicular ovaries. Six of these, at 1 year after menarche, showed a uterine cross-sectional area larger than normal for gynecological age (21.92 +/- 5.64 cm(2) vs. 16.36 +/- 2.34 cm(2)). Further serial echographic studies and a careful follow-up will demonstrate if both multifollicular ovaries and increased uterine cross-sectional area in obese girls are precocious signs of polycystic ovaries.

SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE